First transperineal prostate biopsy in Sultanate conducted at SQCCCRC
The Genitourinary (GU) team at the Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) performed the first-of-its-kind operation in Oman for taking a sample of the prostate through the perineum which is safer and more accurate.
Dr. Hilal Al Rashdi, Consultant of Urology Oncology said: “In transperineal biopsy, doctor passes the biopsy needle through the perineal skin into the prostate, rather than passing the biopsy needle through a potentially contaminated rectum. This approach lowers the risk of sepsis to 1 in 500, rather than the approximate 1 to 2 in 100 risk of sepsis related to transrectal biopsy.”
Higher detection rateStudies show a slightly higher detection rate with the transperineal approach, and the main benefit is safety, due to the lower risk of severe life-threatening infection.
Dr Jamsari Khalid, Consultant Radiatian Oncologist added: “with a transperineal approach it is much easier to access the anterior prostate, which is not well sampled with transrectal biopsy.So, nowadays all guidelines advise TP approach as first choice if available.”
Prostate biopsyThe urologist recommends a prostate biopsy if results from initial tests, such as a prostate-specific antigen (PSA) blood test or digital rectal exam, suggest that the patient may have prostate cancer.
Tissue samples from the prostate biopsy are examined under a microscope for all cell abnormalities that are a sign of prostate cancer.If cancer is present, it is evaluated to determine how quickly it’s likely to progress and to determine the best treatment options for the patient.